EFX
40
4
AAP
30
3
WYNN
15
-11
CSX
57
4
KMB
34
6
ADI
45
-2
AIV
51
4
AMGN
42
-5
AVB
54
9
CME
56
3
GD
44
2
HCP
54
7
WEC
45
4
QRVO
4
2
KHC
20
2
WMB
63
3
INTC
44
5
COF
60
3
AKAM
54
3
USB
46
3
EFX
40
4
AAP
30
3
WYNN
15
-11
CSX
57
4
KMB
34
6
ADI
45
-2
AIV
51
4
AMGN
42
-5
AVB
54
9
CME
56
3
GD
44
2
HCP
54
7
WEC
45
4
QRVO
4
2
KHC
20
2
WMB
63
3
INTC
44
5
COF
60
3
AKAM
54
3
USB
46
3
Financhill
Back

Gilead Sciences 10K Form

Buy
62

GILD
Gilead Sciences

Last Price:
90.20
Seasonality Move:
8.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $1.2B
Price / Cash Flow: 16.39
Annual Sales: $14.67
Price / Book: 6.14

Profitability

EPS (TTM): 0.82000
Net Income (TTM): $1.05B
Gross Margin: $20.62B
Return on Equity: 5.18%
Return on Assets: 1.78%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.28
Current Ratio: 1.14
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 20.05
Forward P/E Ratio: 12.43

GILD Technical Analysis vs Fundamental Analysis

Buy
62
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $90.22. The Score for GILD is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.